News & events

  • Launch of FlashCell

    Vectalys is proud to launch FlashCell, a new gene therapy company specialized in the development of RNA carriers for therapeutic applications.
  • ASGCT 2017 in Washington, DC

    Vectalys will attend the ASGCT 20th annual meeting in Washington, DC May 10-13, 2017 and will be presenting a poster on efficient KO of PD1 and CXCR4 into primary T cells using LentiFlash.
  • Lentifactory: Horizon 2020 SME Instrument - phase I

    Lentifactory project: Vectalys aims to become a worldwide leader in lentiviral tools manufacturing from research to clinical reach.